Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

First launch for Aggrastat, a new antiplatelet agent for acute coronary syndrome

May 26, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

BLA and MAA filed for recombinant factor VIII product for hemophilia A

May 22, 1998

Fibrinogen receptor antagonists claimed by DuPont Merck

May 22, 1998

U.S. market introduction announced for Plavix

May 22, 1998

DuPont Merck presents new anticoagulants

May 21, 1998

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Recombinant antithrombin III pivotal clinical trials begin

May 18, 1998

Merck characterizes new orally bioavailable thrombin inhibitor: L-374087

May 18, 1998

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.